CA3091105A1 - Compositions from cacao pericarp and methods of producing and using them - Google Patents
Compositions from cacao pericarp and methods of producing and using them Download PDFInfo
- Publication number
- CA3091105A1 CA3091105A1 CA3091105A CA3091105A CA3091105A1 CA 3091105 A1 CA3091105 A1 CA 3091105A1 CA 3091105 A CA3091105 A CA 3091105A CA 3091105 A CA3091105 A CA 3091105A CA 3091105 A1 CA3091105 A1 CA 3091105A1
- Authority
- CA
- Canada
- Prior art keywords
- flour
- composition
- pericarp
- cacao
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000299461 Theobroma cacao Species 0.000 title claims abstract description 86
- 238000000034 method Methods 0.000 title claims abstract description 81
- 239000000203 mixture Substances 0.000 title claims abstract description 70
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 title claims description 70
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 title claims description 70
- 235000001046 cacaotero Nutrition 0.000 title claims description 70
- 235000013312 flour Nutrition 0.000 claims abstract description 84
- 238000001035 drying Methods 0.000 claims abstract description 44
- 235000013305 food Nutrition 0.000 claims abstract description 21
- 238000004108 freeze drying Methods 0.000 claims abstract description 20
- 210000004369 blood Anatomy 0.000 claims abstract description 18
- 239000008280 blood Substances 0.000 claims abstract description 18
- 239000004615 ingredient Substances 0.000 claims abstract description 18
- 238000011282 treatment Methods 0.000 claims abstract description 15
- 239000002537 cosmetic Substances 0.000 claims abstract description 14
- 150000003626 triacylglycerols Chemical class 0.000 claims abstract description 14
- 238000011200 topical administration Methods 0.000 claims abstract 2
- 239000000463 material Substances 0.000 claims description 49
- 230000003078 antioxidant effect Effects 0.000 claims description 24
- 235000013824 polyphenols Nutrition 0.000 claims description 20
- 239000003963 antioxidant agent Substances 0.000 claims description 16
- 235000006708 antioxidants Nutrition 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 16
- 241000282412 Homo Species 0.000 claims description 13
- 230000000694 effects Effects 0.000 claims description 13
- 230000000699 topical effect Effects 0.000 claims description 13
- 229930003935 flavonoid Natural products 0.000 claims description 12
- 235000017173 flavonoids Nutrition 0.000 claims description 12
- 150000002215 flavonoids Chemical class 0.000 claims description 12
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 12
- 239000013589 supplement Substances 0.000 claims description 12
- 239000010903 husk Substances 0.000 claims description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 9
- 235000013361 beverage Nutrition 0.000 claims description 9
- 239000008103 glucose Substances 0.000 claims description 9
- 210000003205 muscle Anatomy 0.000 claims description 9
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 8
- 235000012054 meals Nutrition 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-3',4',5,7-Tetrahydroxy-2,3-trans-flavan-3-ol Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 6
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 claims description 6
- 229930013783 (-)-epicatechin Natural products 0.000 claims description 6
- 235000007355 (-)-epicatechin Nutrition 0.000 claims description 6
- 230000007423 decrease Effects 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 230000003020 moisturizing effect Effects 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims description 2
- 230000000069 prophylactic effect Effects 0.000 claims description 2
- 229960003471 retinol Drugs 0.000 claims description 2
- 239000011607 retinol Substances 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000013256 coordination polymer Substances 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 abstract description 15
- 230000037303 wrinkles Effects 0.000 abstract description 13
- 235000009470 Theobroma cacao Nutrition 0.000 abstract description 11
- 241001465754 Metazoa Species 0.000 abstract description 8
- 238000010438 heat treatment Methods 0.000 abstract description 6
- 230000000975 bioactive effect Effects 0.000 abstract description 5
- 206010040829 Skin discolouration Diseases 0.000 abstract description 3
- 239000002699 waste material Substances 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 238000011872 anthropometric measurement Methods 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 231100000257 skin discolouration Toxicity 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 239000006071 cream Substances 0.000 description 17
- 239000000902 placebo Substances 0.000 description 17
- 229940068196 placebo Drugs 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 235000014510 cooky Nutrition 0.000 description 15
- 235000015872 dietary supplement Nutrition 0.000 description 13
- 235000012041 food component Nutrition 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- 244000046052 Phaseolus vulgaris Species 0.000 description 12
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 12
- 239000005417 food ingredient Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 9
- 230000009286 beneficial effect Effects 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- -1 conditioners Substances 0.000 description 7
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 7
- ZTOJFFHGPLIVKC-YAFCTCPESA-N (2e)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S\1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C/1=N/N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-YAFCTCPESA-N 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 230000002354 daily effect Effects 0.000 description 6
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000344 soap Substances 0.000 description 5
- 229940100611 topical cream Drugs 0.000 description 5
- 235000010489 acacia gum Nutrition 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 210000001142 back Anatomy 0.000 description 4
- 235000019219 chocolate Nutrition 0.000 description 4
- 229940074391 gallic acid Drugs 0.000 description 4
- 235000004515 gallic acid Nutrition 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 229920000084 Gum arabic Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000000643 oven drying Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 239000002884 skin cream Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 108010064851 Plant Proteins Proteins 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000007894 caplet Substances 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 238000009223 counseling Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 235000017807 phytochemicals Nutrition 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229930000223 plant secondary metabolite Natural products 0.000 description 2
- 235000021118 plant-derived protein Nutrition 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 230000037370 skin discoloration Effects 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 235000013322 soy milk Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- ZTOJFFHGPLIVKC-UHFFFAOYSA-N 3-ethyl-2-[(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C1=NN=C1SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-UHFFFAOYSA-N 0.000 description 1
- 238000010269 ABTS assay Methods 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 241000145179 Hilaria jamesii Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 238000013494 PH determination Methods 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000219161 Theobroma Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 229920001938 Vegetable gum Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- ZMBWDDDYLYNBHS-UHFFFAOYSA-N acetic acid;propan-2-one;hydrate Chemical compound O.CC(C)=O.CC(O)=O ZMBWDDDYLYNBHS-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000798 anti-retroviral effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003524 antilipemic agent Substances 0.000 description 1
- 229940124522 antiretrovirals Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000013588 oral product Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000008833 sun damage Effects 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C4/00—Crushing or disintegrating by roller mills
Landscapes
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
The cocoa pod pericarp (CP) is used to produce a nutritional ingredient in the form of flour using convection heating, freeze-drying and or microwave drying. The dry CP physical and technological properties observed show that it can be potentially used as an ingredient of manufactured food products. The bioactive compound levels increased significantly in the dry CP samples, as compared with raw materials, especially in the case of freeze-drying methods. The cocoa pod waste material can be used in a commercially advantageous manner for the treatment of humans and animals in order to improve anthropometric measurements or cardiometabolic blood markers, and to improve body mass and composition. The modalities for treating humans and animals include oral administration to reduce the LDL/HDL ratio or the proportion of triglycerides/HDL, or topical administration as a cosmetic treatment to reduce fine lines, wrinkles, skin discolouration and other skin disorders.
Description
COMPOSITIONS FROM CACAO PERICARP AND METHODS OF PRODUCING AND
USING THEM
REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority to U.S. provisional patent application 62/458,408, filed February 13, 2017, the entire contents of which are incorporated herein by reference.
FIELD OF THE INVENTION AND INTRODUCTION
USING THEM
REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority to U.S. provisional patent application 62/458,408, filed February 13, 2017, the entire contents of which are incorporated herein by reference.
FIELD OF THE INVENTION AND INTRODUCTION
[0002] The invention relates to economically advantageous uses of the pericarp from the pod of the Theobroma cacao plant and comestible products and compositions derived from this material. The pericarp from the cacao pod is typically a waste product in cacao bean production and the methods described here make use of what formerly would be discarded cacao material. In particular, the invention employs the pericarp of the pod and its commercial use in producing a dietary supplement or food ingredient. Also, as shown here, are methods of the invention that result in compositions that possess unexpectedly high levels of beneficial compounds, resulting in products and treatments for reducing blood triglyceride levels, for reducing LDL levels, for reducing blood glucose levels, for weight maintenance and loss, for reducing waist circumference, for improving muscle strength, and for improving other cardiometabolic markers in the blood. In another aspect, the pericarp material can be used to make a topical cosmetic composition, and in one example a topical cream, that can treat skin discoloration, wrinkles and fine lines, and other condition of the skin.
BACKGROUND
BACKGROUND
[0003] Theobroma cacao pericarp (CP) is an agricultural by-product generated in abundance on plantations and farms when mature cacao seeds or beans are removed for bean processing. The term CP is used here because it is a specific term defined by in plant biology and Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 refers to the outer tissues of the cacao pod. Cuatrecasas, J., Cacao and Its Allies: A Taxonomic Revision of the Genus Theobroma, Contributions from the United States National Herbarium (Washington DC) 35, part 6. 1964. The pericarp surrounds the cacao seed and the surrounding seed pulp. Other casual terms that may be found in the prior art may include cacao hull, cacao shell and cacao pod, but these terms are confusing and frequently are used to refer to structures of the cacao beans, such as the seed coat. In the chocolate industry, the seed coat is part of whole cacao beans that has been typically fermented and dried. This seed material is not pericarp. The seed material can, and often is, referred to as shell, cacao bean husk, pod, husk or hull material in scientific literature and patent documents. The seed coat is removed from cacao seed either before or after bean roasting and before chocolate manufacture begins. So to avoid confusion the term CP (Theobroma cacao pericarp) will be used in this invention.
[0004] The CP is a major waste product of the cacao bean production on farms or plantations, and hence for the cacao bean production industry (Yapo, B.M. et al. Adding value to cocoa pod husks as a potential antioxidant-dietary fiber source. Am. J. Food Nutr. 1, 38-46. 2013 Karim et al., Phenolic composition, antioxidant, anti-wrinkles and tyrosinase inhibitory activities of cocoa pod extract. BMC complementary and alternative medicine, 14, 381 (2014). According to the International Cocoa Organization (ICCO), 4.4 million tons of cacao beans were produced during 2013-2014, and approximately 3 million tons of CP were discarded on farms and plantations, causing environmental problems, foul odors, and propagating diseases, such as black pod rot (ICCO 2015, Karim et al., 2014, Vriesmann et al., 2011, Vriesmann et al., 2012).
[0005] In Mexico and other cacao-producing countries, the processing of cacao pericarp (CP) into useful byproducts could provide economic advantages to farmers and reduce environmental problems (Vriesmann et al., Cacao pod husks (Theobroma cacao L.): composition Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 and hot-water-soluble pectins. Industrial Crops and Products, 34, 1173-1181 (2011). CP is rich in a variety of compounds, making it a promising source of such molecules;
thus, could hold potential for the production of useful natural compounds. The total phenolic content of cacao pod husk is 46.4 0.04 mg of gallic acid equivalents/g, demonstrating that it is a rich source of phenolic compounds that could be used rather than discarded (Karim et al., 2014).
thus, could hold potential for the production of useful natural compounds. The total phenolic content of cacao pod husk is 46.4 0.04 mg of gallic acid equivalents/g, demonstrating that it is a rich source of phenolic compounds that could be used rather than discarded (Karim et al., 2014).
[0006] However, conserving the phenol content of CP is challenging because this material decomposes rapidly, especially in hot, moist, humid tropical climates. In addition, the location of most cacao plantations does not generally allow for local storage or preservation methods.
Perishable fruits, vegetables and other agro-industrial by-products can be dehydrated to preserve them for subsequent use (Si et al., Comparison of different drying methods on the physical properties, bioactive compounds and antioxidant activity of raspberry powders.
Journal of the Science of Food and Agriculture (2015). Dehydration extends the shelf life of the final food product, allowing its convenient long-term storage and future use in the manufacture of food, beverages or supplements. Among the different drying processes that are utilized, hot-air drying is commonly used in food production because it is an affordable method, although the long drying period can result in an inferior product quality.
Perishable fruits, vegetables and other agro-industrial by-products can be dehydrated to preserve them for subsequent use (Si et al., Comparison of different drying methods on the physical properties, bioactive compounds and antioxidant activity of raspberry powders.
Journal of the Science of Food and Agriculture (2015). Dehydration extends the shelf life of the final food product, allowing its convenient long-term storage and future use in the manufacture of food, beverages or supplements. Among the different drying processes that are utilized, hot-air drying is commonly used in food production because it is an affordable method, although the long drying period can result in an inferior product quality.
[0007] In addition, the use of high temperatures for dehydration is controversial because naturally bioactive compounds are relatively unstable under heat and, thus, nutrients can be lost during thermal processing (Choi et al., 2006). Conversely, studies have shown that the phytochemical content and antioxidant and biological activities of processed foods may be increased by heat treatment causing degradation of cellular constituents, thus promoting the release of phytochemicals into media (Choi et al., 2006, Wojdylo et al., 2009).
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
[0008] Although various methods and conditions for drying are presumed to differentially affect the quality and quantity of the bioactive compounds present in fruits and vegetables, there is no information regarding the effect of using drying techniques on the bioactive compounds present in CP. Furthermore, nothing is known about the beneficial effect of such methods on the polyphenol or antioxidant content in these materials when consumed by humans.
[0009] The invention, in part, addresses these shortcomings and provides compositions produced from CP material that can be used for human and animal consumption.
As explained below, the methods of the invention can be used to produce a food supplement or a food ingredient that, when consumed regularly, advantageously leads to a dramatic reduction in blood triglyceride levels, and beneficial improvement in both LDL and HDL levels. Furthermore, methods of treating subjects with the CP food supplement or ingredient result in weight loss and improvements in muscle strength. In another aspect, the CP material is used to make a topical cosmetic composition or a topical cream that can be used treat skin discoloration, wrinkles, fine lines, or other conditions of the skin.
BRIEF SUMMARY OF THE INVENTION
As explained below, the methods of the invention can be used to produce a food supplement or a food ingredient that, when consumed regularly, advantageously leads to a dramatic reduction in blood triglyceride levels, and beneficial improvement in both LDL and HDL levels. Furthermore, methods of treating subjects with the CP food supplement or ingredient result in weight loss and improvements in muscle strength. In another aspect, the CP material is used to make a topical cosmetic composition or a topical cream that can be used treat skin discoloration, wrinkles, fine lines, or other conditions of the skin.
BRIEF SUMMARY OF THE INVENTION
[0010] In one aspect, the invention provides a new, rich source of beneficial cacao-derived compounds, such as antioxidants, polyphenols, and flavonoids. In another aspect, this invention provides methods of treating humans and animals to improve the levels of several blood markers associated with disease and/or improved health. In another aspect, the invention encompasses commercially advantageous methods of producing a food supplement, ingredient or functional food made at least in part from the cacao pod husk pericarp material. The "pericarp" is distinguished by three layers: the exocarp or outer skin of the pod; the thick white mesocarp just below the exocarp; and a thin translucent inner layer called the endocarp (see Figure 1).
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 Collectively these layers comprise the outer part of the cacao fruit or pod and are collectively referred to as the pericarp. The cacao seeds or beans and the outer layer or membrane surrounding the seeds are distinct from the pericarp. The seeds or beans are also surrounded in the pod by a mucilaginous pulp material, which again, are distinct from the pericarp. Cacao nibs, the part of the seed used in chocolate manufacture, are surrounded by the cacao shell, and the nibs and the cacao shell are not part of the pericarp.
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 Collectively these layers comprise the outer part of the cacao fruit or pod and are collectively referred to as the pericarp. The cacao seeds or beans and the outer layer or membrane surrounding the seeds are distinct from the pericarp. The seeds or beans are also surrounded in the pod by a mucilaginous pulp material, which again, are distinct from the pericarp. Cacao nibs, the part of the seed used in chocolate manufacture, are surrounded by the cacao shell, and the nibs and the cacao shell are not part of the pericarp.
[0011] In a more specific aspect, the invention includes a method for the preparation of a "flour" food ingredient or composition from CP. The method comprises isolating pericarp material from cacao pods, where the pericarp material is free of cacao seeds and pulp, forming a paste and drying the pericarp paste, and then grinding the dried material into a flour-type product or processing it into another food ingredient, such as a powder, paste, or extract. In preferred embodiments, the method employs a freeze dying step under vacuum pressure until the pericarp material has a moisture level of 10% or less, or 8% or less. In another preferred embodiment, the method employs a microwave drying step until the pericarp material has a moisture level of 10%
or less, or 8% or less, or 5% or less. The pericarp material can be ground to obtain pericarp flour with a particle size of less than 0.500 mm, or less than 0.425 mm.
or less, or 8% or less, or 5% or less. The pericarp material can be ground to obtain pericarp flour with a particle size of less than 0.500 mm, or less than 0.425 mm.
[0012] In any of the methods or the uses of the compositions described here, the invention can include measuring the total polyphenol content, total flavonoid content, and/or antioxidant capacity of the pericarp material or the flour composition or food ingredient.
Thus, the invention allows the production of compositions and the monitoring of the advantageously high levels of beneficial cacao-derived flavonoids and polyphenols in those compositions.
Thus, the invention allows the production of compositions and the monitoring of the advantageously high levels of beneficial cacao-derived flavonoids and polyphenols in those compositions.
[0013] In another aspect, the invention encompasses methods for enhancing the antioxidation capacity of cacao pod husk material comprising isolating pericarp material from Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 cacao pods after harvesting cacao seeds from the pods so that the pericarp material is substantially free of cacao seeds and pulp material, then drying the pericarp material to a moisture level of 10%
or less, or 8% or less. The dried material is then ground to form a flour composition or other food ingredient. The method of drying can be selected from one or more of freeze drying under vacuum, oven heating, and microwave treatment. The methods can further comprise measuring the polyphenol oxidase activity of the pericarp material or the flour composition or food ingredient.
or less, or 8% or less. The dried material is then ground to form a flour composition or other food ingredient. The method of drying can be selected from one or more of freeze drying under vacuum, oven heating, and microwave treatment. The methods can further comprise measuring the polyphenol oxidase activity of the pericarp material or the flour composition or food ingredient.
[0014] In another aspect, the invention includes prophylactic methods and methods of treating a human subject and/or animals by providing a CP ingredient derived only from the pericarp of the pod, and administering the ingredient daily or multiple times per day. For human subjects in particular, the amount delivered daily will optimally include enough of the pericarp-derived cacao composition to deliver about 12.5 mg of total cacao flavonoids measured in equivalents of (-)-epicatechin per dose. Other amounts, dosages, and administration regimens can also be used and adopted. In embodiments of the invention related to methods of treating animals or humans, or methods of treating or preventing disease in humans or animals, the antioxidant capacity of cacao-derived material improves physiological markers associated with certain disease conditions. For example, one or more of the following markers or measurements can be used:
triglyceride levels; LDL levels; glucose levels; LDL/HDL ratio, Body Mass Index; muscle mass;
or triglyceride/HDL ratio. Accordingly, daily treatments with beneficial cacao-derived compounds, or the cacao pod husk pericarp flour described here, can advantageously improve health or prevent disease.
triglyceride levels; LDL levels; glucose levels; LDL/HDL ratio, Body Mass Index; muscle mass;
or triglyceride/HDL ratio. Accordingly, daily treatments with beneficial cacao-derived compounds, or the cacao pod husk pericarp flour described here, can advantageously improve health or prevent disease.
[0015] In other aspects, the methods for preparing ingredients and compositions can result in a flour-like composition, a paste, and/or an extract of CP. Various extraction methods are known in the art and can include the use of food-approved chemicals and solvents.
Administering the Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 ingredients or compositions may be done with any suitable carrier, in solid or liquid dosage form such as tablets, capsules, powders, soft gels, solutions, suspensions, emulsions, ointments, or creams. The ingredient or composition may also be administered as a food supplement or as a functional food ingredient. An extract of the pericarp material or flour may be used alone or combined with one or more other plant extracts to produce a composition optimized for a particular functional effect. Further, an extract composition may be formulated with one or more other dietary nutrients, such as vitamins minerals, amino acids, etc., to provide a functional or nutritional supplement for a desired health effect. These ingredients may be combined with necessary binders, excipients, preservatives, colors and the like known to those in the industry or commonly used or described in similar products in order to produce a suitable tablet, capsule, pill, liquid, cream, powder, or food ingredient. As noted, some of these ingredients or compositions can also be used for topical treatments or used in cosmetic products.
Administering the Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 ingredients or compositions may be done with any suitable carrier, in solid or liquid dosage form such as tablets, capsules, powders, soft gels, solutions, suspensions, emulsions, ointments, or creams. The ingredient or composition may also be administered as a food supplement or as a functional food ingredient. An extract of the pericarp material or flour may be used alone or combined with one or more other plant extracts to produce a composition optimized for a particular functional effect. Further, an extract composition may be formulated with one or more other dietary nutrients, such as vitamins minerals, amino acids, etc., to provide a functional or nutritional supplement for a desired health effect. These ingredients may be combined with necessary binders, excipients, preservatives, colors and the like known to those in the industry or commonly used or described in similar products in order to produce a suitable tablet, capsule, pill, liquid, cream, powder, or food ingredient. As noted, some of these ingredients or compositions can also be used for topical treatments or used in cosmetic products.
[0016] In another aspect, the CP flour composition can be used in a topical cosmetic composition, and in one example a topical cream. The various CP compositions described herein can be blended with a cosmetically acceptable carrier, which may include purified water, oils, alcohols, glycols, other cosmetically acceptable components available, and combinations thereof.
The topical cosmetic compositions and the methods of using them employ the CP
flour present in a range from approximately 0.1% to 1% by weight, or 0.05% to 1% by weight, or 0.05% to 5% by weight, for example.
The topical cosmetic compositions and the methods of using them employ the CP
flour present in a range from approximately 0.1% to 1% by weight, or 0.05% to 1% by weight, or 0.05% to 5% by weight, for example.
[0017] In yet another aspect, the topical cosmetic composition may further comprise additional ingredients such as penetration enhancers, humectants, lubricants, pharmaceutically active agents, color agents, fragrance, preservatives, antioxidants, chelators, neutralizers, amino acids, anti-inflammatory agents, anti-irritants, anti-tack agents, astringents, binders, catalysts, Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 stabilizers, emollients, emulsifiers, surfactants, cell-signaling agents, retinols, essential oils, plant/botanical extracts, conditioners, film formers, gelling agents, foaming agents, exfoliants, vitamins, minerals, pH adjusters, proteins, peptides, tactile enhancers, saccharides, solvents or any combination thereof.
[0018] In still another aspect, the topical skin care composition may be formulated as a cream, lotion, serum, facial cleanser, toner, eye cream, sunscreen, stick, spray, impregnated personal care device, impregnated towelette, gel, fluid/liquid, soap, oil, butter, peel, scrub, mask, concentrate, or any other form known in the art.
[0019] In another aspect, the present invention includes a topical skin care composition comprising a CP flour composition and a cosmetically acceptable carrier together with and one or more of the following: (a) a source of bio-retinol (b) a source of retinol-like activity; (c) a source of sodium hyaluronic acid or other cosmetically active acid; (d) a source of moisturizing saccharide complex; (e) an ascorbic acid source; and (f) a source of anti-oxidant components.
[0020] In still another aspect, a topical cosmetic composition in accordance with principles of the invention or the examples below is applied to the skin, such as the hands or face, which may have, for example, but not limited to, wrinkles, fine lines, uneven tone, loss of firmness, surface roughness, dark circles, under-eye puffiness, sun damage, redness, dryness, irritation, enlarged ports and combinations of all or some of the above. Alternatively, the topical cosmetic composition may be applied to the skin to prevent the occurrence of the various problems described above. Thus, the invention includes methods of treating and preventing skin conditions using a CP flour composition in a cosmetically acceptable carrier. Such methods include the daily use of the topical cosmetic composition on skin, and the use at multiple times during a day, for a period of time such as four weeks or more.
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
[0021] The invention is not limited by the foregoing, or the following Drawings, Description, Claims, or Examples, but can be appreciated in its full extent from the entire contents of this disclosure. None of the cited references or information should be taken to limit or modify any specific description or definition as used in this disclosure.
DESCRIPTION OF THE DRAWINGS
DESCRIPTION OF THE DRAWINGS
[0022] Figure 1 is a top view of a cross-sectional image of a Theobroma cacao pod showing the layers of plant matter and the relative location of the seeds, exocarp, mesocarp, and endocarp (Cuatrecasas, J. 1964). The "pericarp" is distinguished by three layers; the exocarp or outer skin; the thick white mesocarp just below the exocarp, and a thin translucent inner layer called the endocarp. Collectively these layers comprise the outer part of the fruit and are of maternal origin. The seeds are surrounded by a mucilaginous pulp material, and both the seeds and the pulp are not part of the pericarp.
[0023] Figure 2 is a schematic showing a side cross-sectional view of a Theobroma cacao pod listing the location of the seeds, exocarp, mesocarp, and endocarp.
[0024] Figure 3 shows the total phenolic content (TPC) and total flavonoid content (TFC) of fresh and dry CP flour prepared by different methods: OHD - oven heat drying; MWD -microwave drying; and FD - freeze drying. Total phenolic content is expressed as mg gallic acid equivalent/100 g sample dry mass (DM) and total flavonoid content is expressed as mg of (-)-epicatechin equivalent/100 g sample dry mass. Levels on graphs that list different letters are statistically significant (p<0.05).
[0025] Figure 4 shows the changes in hand grip strength after 8 weeks of consumption of the placebo or the experimental cookie (galletas) treatment (placebo cookies and CP flour-Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 containing cookies). There is a positive and significant increase in strength with regular treatment of CP flour.
[0026] Figure 5 illustrates an example of wrinkles noted in the hand dorsum of a volunteer before the application of a CP based skin cream and after 4 weeks of local application.
[0027] Figure 6 summarizes changes noted in the total height of hand dorsum wrinkles noted in subjects exposed to 4 weeks of either a placebo or a CP based skin cream. As can be noted a statistically significant reduction in the total height of wrinkles is noted in CP treated subjects.
[0028] Figure 7 summarizes changes noted in the color of the hand dorsum noted in subjects exposed to 4 weeks of either a placebo or a CP based skin cream. As can be noted a statistically significant reduction in the dorsum hand color is noted in CP
treated subjects.
DETAILED DESCRIPTION AND EXAMPLES
treated subjects.
DETAILED DESCRIPTION AND EXAMPLES
[0029] The invention in one aspect generally encompasses a method of producing and using a food ingredient from specific parts of the CP material. The ingredient, which can be formed as a flour for baking or food manufacture, can be used to produce edible and health-promoting products, such as wafers, baked cookies, cakes, and similar products. The ingredient can also be used as a supplement to be added to other food products or as a dietary supplement in pill or formulated form.
[0030] As noted above, the preferred form for using the pericarp material is as a flour-type composition that is capable of being used as a food ingredient or in a food product, such as a baked food. However, the invention is not limited to this preferred form or use. In particular, the compositions or extracts of the CP material of the invention can also be used as a nutritional supplement. In such form, the compositions may be introduced into a base carrier or onto a carrier.
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 The nutritional supplement may be enclosed within a capsule, typically a water soluble capsule, but could be water dispersible, thus releasing the nutritional supplement once mixed with water.
A capsule could also comprise one or more of a gum, such as acacia gum and Arabic gum, methyl cellulose gum, dextrin, gelatin, casein, milk powder, skimmed milk powder, soya protein, plant protein, or other protein. Alternatively, or in addition, the nutritional supplement can be carried on a granular, flake or particulate carrier, which again could be one or more of gum, such as acacia gum, gum Arabic, dextrin, methyl cellulose gum, gelatin, soya, plant protein, legume seed protein, soya milk, soya milk powder, soya protein, casein, vegetable gum, cellulose, starch, sugar, glucose, and/or maltodextrin.
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 The nutritional supplement may be enclosed within a capsule, typically a water soluble capsule, but could be water dispersible, thus releasing the nutritional supplement once mixed with water.
A capsule could also comprise one or more of a gum, such as acacia gum and Arabic gum, methyl cellulose gum, dextrin, gelatin, casein, milk powder, skimmed milk powder, soya protein, plant protein, or other protein. Alternatively, or in addition, the nutritional supplement can be carried on a granular, flake or particulate carrier, which again could be one or more of gum, such as acacia gum, gum Arabic, dextrin, methyl cellulose gum, gelatin, soya, plant protein, legume seed protein, soya milk, soya milk powder, soya protein, casein, vegetable gum, cellulose, starch, sugar, glucose, and/or maltodextrin.
[0031] Advantageously, a dietary supplement using the CP material can be provided in a caplet form for consumption one or several times per day. For instance, in one embodiment, the dietary supplement comprises a single caplet serving, each serving suitable for being consumed one or three or more times daily, e.g., at, before or between meals as appropriate.
[0032] In alternative embodiments, a pharmaceutical composition containing at least an extract of the cacao polyphenol of the pericarp material described herein, in an amount sufficient to achieve a desired effect in a subject, can be prepared. This composition may be a tablet, a liquid, capsules, soft capsule, paste or pastille, gum, or as a drinkable solution or emulsion, a dried oral supplement, or even a wet oral supplement. The pharmaceutical composition can further contain carriers and excipients that are suitable for delivering the biologically active compounds from cacao as well as other compounds of a different nature. The kind of the carrier/excipient and the amount thereof will depend on the nature of the cacao extract or cacao compounds or substance used and the desired mode of delivery and/or administration.
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
[0033] In addition, cosmetic or cosmeceutical compositions can be produced from the CP
material described herein. A topical form can be a solution, emulsion, serum, skin and/or hair cleanser, body wash, body scrub, bar soap, liquid soap, shampoo lather, deodorant, skin and/or hair care preparation, foam, mousse, cream, lotion, pomade, balm, stick, gel, pump spray, aerosol spray, and combinations thereof. In one embodiment, the cosmeceutical compositions of this invention can be used in foams in personal care applications such as soaps, shampoos, skin cleansers, oral products, and the like. The compositions of this invention can thus also comprise a cosmetically acceptable carrier to act as a diluent, dispersant or carrier for the CP ingredients or extracts. The carrier can be one selected to facilitate the distribution and uptake of cacao-derived compounds when the composition is applied or administered. Vehicles other than or in addition to water can include liquid or solid emollients, solvents, humectants, thickeners, powders, and perfumes.
material described herein. A topical form can be a solution, emulsion, serum, skin and/or hair cleanser, body wash, body scrub, bar soap, liquid soap, shampoo lather, deodorant, skin and/or hair care preparation, foam, mousse, cream, lotion, pomade, balm, stick, gel, pump spray, aerosol spray, and combinations thereof. In one embodiment, the cosmeceutical compositions of this invention can be used in foams in personal care applications such as soaps, shampoos, skin cleansers, oral products, and the like. The compositions of this invention can thus also comprise a cosmetically acceptable carrier to act as a diluent, dispersant or carrier for the CP ingredients or extracts. The carrier can be one selected to facilitate the distribution and uptake of cacao-derived compounds when the composition is applied or administered. Vehicles other than or in addition to water can include liquid or solid emollients, solvents, humectants, thickeners, powders, and perfumes.
[0034] The following Examples and descriptions are exemplary only and should not be taken as a limitation on the scope of the invention.
[0035] Example 1: Production of CP Flour
[0036] Step 1: Production of a CP paste.
[0037] Whole cacao pods are washed with soap, rinsed with water, sanitized for 15 min with Citrus210 solution (20 mL/L water, Integra Citrus, Ciudad de Mexico, Mexico). Pods were cut open, the seeds and pulp removed, and only the pericarp of the husk is retained and is ground in a semi-industrial blender (Crypto Peerless K55, USA) until a paste is obtained.
[0038] Step 2: Drying methods of CP paste
[0039] One or more of three methods can be used for drying of CP paste.
Samples were dried using:
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
Samples were dried using:
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
[0040] A. CONVENTIONAL HOT AIR OVEN (CD). 150 g of paste is dried at 60 C
for 24 h (Lindberg Blue OV-484, USA oven).
for 24 h (Lindberg Blue OV-484, USA oven).
[0041] B. FREEZE DRYING (FD). 150 g of paste is dried under vacuum pressure of 20 Pa for 24 h (Scientz, SC-10N, Ningbo, China).
[0042] C. MICROWAVE DRYING (MWD). 150 g of paste is dried at microwave power (595 Watts) for 11.5 min using a Panasonic inverter NN-5N968, 2450 MHz.
[0043] Drying was conducted until the paste samples reached a 4-8%
moisture level.
moisture level.
[0044] Step 3: Sifting and milling of dried paste to produce cacao pericarp flour
[0045] Dried cacao pericarp paste is finely ground using a Cunill luxo mill and sieved to obtain:
[0046] Fine pericarp flour with a particle size < 0.425 mm.
[0047] Coarse pericarp flour with a particle size >0.425 mm.
[0048] Example 2: Characterization of Pericarp Flour Samples
[0049] CP paste has a moisture content of 87.4 0.56 %. The drying process reduces water content to 4.6-7.8% (see Table 1). The results indicate that when using freeze drying methodology, a lower moisture content was obtained compared to conventional and microwave paste drying. Moisture content of pericarp flour showed statistical differences (p<0.05) among the three drying methods used.
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
[0050] Table 1
[0051] Moisture, pH and water activity (Aw) of dried pericarp flour samples DRYING METHOD MOISTURE PER 100 (Aw) pH
G
CD 5.98 0.086 0.373 0.003 5.57 0.007 MWD 7.87 0.38* 0.543 0.32* 5.64 0.02 FD 4.8 0.34*,¨ 0.252 0.018*,¨ 5.7 0.014
G
CD 5.98 0.086 0.373 0.003 5.57 0.007 MWD 7.87 0.38* 0.543 0.32* 5.64 0.02 FD 4.8 0.34*,¨ 0.252 0.018*,¨ 5.7 0.014
[0052] *p<0.05 vs. conventional, ** p<0.05 vs. microwave
[0053] For pH determination, a suspension of lg of sample in 10 mL of distilled water is prepared with continuous stifling it for 2 min. The pH is determined using a pH meter (model pH
210, Hanna Instruments). Water activity of pericarp flour samples is measured using water activity meter Hygropalm aw 1 (a-D10). Triplicate samples are measured at 23.6 2 C.
210, Hanna Instruments). Water activity of pericarp flour samples is measured using water activity meter Hygropalm aw 1 (a-D10). Triplicate samples are measured at 23.6 2 C.
[0054] Water activity (Aw) and pH of dried pericarp flour are important parameters related to product deterioration and degradation. The pH values were similar among the drying methods used resulting in a pH ranging from 5.57 - 5.7 (Table 1). Water activity of the dried pericarp flour had low values ranging from 0.252 (freeze drying) to 0.543 (microwave), showing a statistical difference among them (p<0.05) (Table 1). Interestingly, although microwave drying method presented the highest moisture and Aw values, they are below the safe storage limit conditions that prevent enzymatic and microbiological deterioration, indicating that any of the three drying methods can be used if only the preservation of the CP flour is considered.
[0055] Color assessment of these flour samples can be conducted at room temperature using a color reader (CR-10, Konica-Minolta Sensing Inc., Osaka, Japan). The parameters Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 measured were L* for lightness; C* for chroma; A* for red; B* for yellow.
Total color difference (AE) between fresh cacao and dried pericarp flour was determined using an equation. AE indicates the magnitude of color difference between fresh and dried samples. They can be analytically classified as slight difference (0.5>AE<1.5), noticeable difference (1.5>AE<3), marked difference (3>AE<6), extremely marked difference (6>AE<12), and a color of different shade (AE>12).
Total color difference (AE) between fresh cacao and dried pericarp flour was determined using an equation. AE indicates the magnitude of color difference between fresh and dried samples. They can be analytically classified as slight difference (0.5>AE<1.5), noticeable difference (1.5>AE<3), marked difference (3>AE<6), extremely marked difference (6>AE<12), and a color of different shade (AE>12).
[0056]
Color composition obtained from the three noted drying methods is presented in Table 2. The flour color evaluation showed that the cacao pericarp flour drying method used had significant effects. The main changes after drying were given in Hue* and b*
values, having significantly increased compared to fresh pericarp sample indicating degradation of the original color by turning into more yellowish-brownish color. CP flour dried by three 3 different drying methods showed a wide AE from fresh pericarp sample (>20) indicating a total change of color shade, which can be appreciated at a glance. Freeze drying results in the greatest pericarp color change among the drying methods. The color results after drying treatments are important since color changes could affect the sensory properties of CP flour, limiting its utilization as a food ingredient, and also directly relates to changes in the composition of the separate samples.
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
Color composition obtained from the three noted drying methods is presented in Table 2. The flour color evaluation showed that the cacao pericarp flour drying method used had significant effects. The main changes after drying were given in Hue* and b*
values, having significantly increased compared to fresh pericarp sample indicating degradation of the original color by turning into more yellowish-brownish color. CP flour dried by three 3 different drying methods showed a wide AE from fresh pericarp sample (>20) indicating a total change of color shade, which can be appreciated at a glance. Freeze drying results in the greatest pericarp color change among the drying methods. The color results after drying treatments are important since color changes could affect the sensory properties of CP flour, limiting its utilization as a food ingredient, and also directly relates to changes in the composition of the separate samples.
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
[0057]
Table 2. Color measurements of CP flour obtained using different drying methods.
DRYING HUE
A* B* C* L* AE
METHOD ANGLE
FRESH 8.8 1.2 10.2 1.41 13.4 1.9 36.1 0.4 49.2 0.1 -CD 9 0.1 17.3 0.2* 19.5 0.3* 54.9 0.2*
62.4 0.1* 20.2 1.1*
MWD 9.4 0.2 19.4 0.2* 21.4 0.2* 56.2 0.2*
63.8 0.1* 22.2 1*
FD 11.97 0.1* 21.3 0.1* 24.4 0.1* 56.5 0.1*
60.7 0.2* 23.5 1.2*
Table 2. Color measurements of CP flour obtained using different drying methods.
DRYING HUE
A* B* C* L* AE
METHOD ANGLE
FRESH 8.8 1.2 10.2 1.41 13.4 1.9 36.1 0.4 49.2 0.1 -CD 9 0.1 17.3 0.2* 19.5 0.3* 54.9 0.2*
62.4 0.1* 20.2 1.1*
MWD 9.4 0.2 19.4 0.2* 21.4 0.2* 56.2 0.2*
63.8 0.1* 22.2 1*
FD 11.97 0.1* 21.3 0.1* 24.4 0.1* 56.5 0.1*
60.7 0.2* 23.5 1.2*
[0058]
Color difference (AE) is calculated using the fresh pericarp cacao flour (Fresh) as reference.
Color difference (AE) is calculated using the fresh pericarp cacao flour (Fresh) as reference.
[0059] * = (p<0.05) vs fresh.
[0060]
Biochemical assessment of the CP flour extract can use total phenolic or flavonoid content determinations or the antioxidant activity from the method described by Martinez et al.
(2012) with modifications. Five hundred milligrams of fresh and dry CP flours are stirred at room temperature for 60 min with 20 mL of acetone-water-acetic acid (70:29.5:0.5).
These samples are centrifuged at 3,500 g, 15 min at 4 C and the supernatants kept at -20 C until used.
Biochemical assessment of the CP flour extract can use total phenolic or flavonoid content determinations or the antioxidant activity from the method described by Martinez et al.
(2012) with modifications. Five hundred milligrams of fresh and dry CP flours are stirred at room temperature for 60 min with 20 mL of acetone-water-acetic acid (70:29.5:0.5).
These samples are centrifuged at 3,500 g, 15 min at 4 C and the supernatants kept at -20 C until used.
[0061]
Total phenolic content (TPC) was determined using the Folin-Ciocalteu's reaction.
A volume of 0.3 mL of the flour extracts is poured by triplicate into test tubes, adding 2.5 mL of Folin-Ciocalteu's reagent (diluted 1:10 with double distilled water) and 2 mL
of sodium bicarbonate solution (7.5% w/v). Tubes are - rapidly stirred and mixed using a vortex stirrer, covered with parafilm and incubated at 50 C for 5 min. Absorption at 760 nm is measured with a Genesys 10 UV spectrophotometer. Concentration is determined using gallic acid standard curves and results are expressed as mg of gallic acid equivalents (GAE)/g dry mass (mean SD).
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
Total phenolic content (TPC) was determined using the Folin-Ciocalteu's reaction.
A volume of 0.3 mL of the flour extracts is poured by triplicate into test tubes, adding 2.5 mL of Folin-Ciocalteu's reagent (diluted 1:10 with double distilled water) and 2 mL
of sodium bicarbonate solution (7.5% w/v). Tubes are - rapidly stirred and mixed using a vortex stirrer, covered with parafilm and incubated at 50 C for 5 min. Absorption at 760 nm is measured with a Genesys 10 UV spectrophotometer. Concentration is determined using gallic acid standard curves and results are expressed as mg of gallic acid equivalents (GAE)/g dry mass (mean SD).
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
[0062] Total polyphenol content (TPC) of CP flour samples are shown in Figure 3.
Polyphenolic content was different (p<0.05) among the three drying methods used. The highest concentration was found in freeze-dried CP flour followed by microwave dried and the lowest by conventional oven drying. Freeze drying likely caused the retention of the most phenolic content since the method of drying does not use heat to dry samples, while with conventional oven drying, oxidative and thermal degradation or cross-link of polyphenols with pericarp structures probably increase given the long duration of the heat treatment. Interestingly, microwave drying process retained a considerable amount of phenolic compounds (a few mg below freeze drying) since it applies a short heating time, therefore, diminishing thermal degradation.
Polyphenolic content was different (p<0.05) among the three drying methods used. The highest concentration was found in freeze-dried CP flour followed by microwave dried and the lowest by conventional oven drying. Freeze drying likely caused the retention of the most phenolic content since the method of drying does not use heat to dry samples, while with conventional oven drying, oxidative and thermal degradation or cross-link of polyphenols with pericarp structures probably increase given the long duration of the heat treatment. Interestingly, microwave drying process retained a considerable amount of phenolic compounds (a few mg below freeze drying) since it applies a short heating time, therefore, diminishing thermal degradation.
[0063] Total flavonoid content (TFC) can be determined following the method described by Maleyki & Ismail, 2010. One milliliter of the cacao pericarp flour extract and 0.3 ml of NaNO2 (0.5%) were added. The mixture is allowed to react by 5 min after adding 0.3 mL of A1C13 6H20 (10%). The mixture was stirred and allowed to react for 6 min. Two mL of 1 M
NaOH were added and total volume adjusted to 10 mL with water. A UV spectrophotometer is used to read the absorbance at 510 nm. TFC is calculated with a calibration curve using (-)-epicatechin and expressed as mg (-)-epicatechin equivalents/g dry mass.
NaOH were added and total volume adjusted to 10 mL with water. A UV spectrophotometer is used to read the absorbance at 510 nm. TFC is calculated with a calibration curve using (-)-epicatechin and expressed as mg (-)-epicatechin equivalents/g dry mass.
[0064] TFC results are also shown in Figure 3. Flavonoid content was different (p<0.05) amongst the 3 drying methods used. The highest concentration was found in freeze-dried cacao pericarp flour followed by microwave dried and the lowest by conventional oven. Microwave drying process retained a considerable amount of flavonoids
[0065] Antioxidant activity can be determined by the radical scavenging properties of the flour samples, evaluated using the method previously reported by Brand-Williams et al, with some modifications. A stock solution is prepared by dissolving 24 mg DPPH (2, 2-dipheny1-1-Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 picrylhydrazyl) with 100 mL of methanol and then stored at -20 C until needed. The DPPH
solution is obtained by mixing 10 mL stock solution with 45 mL methanol until an absorbance of 1.1 0.02 units at 515 nm is obtained using the spectrophotometer. CP flour extracts (0.150 mL) were allowed to react with 2.85 mL of the DPPH solution for 2 h in the dark.
Absorbance is measured at 515 nm using a UV-VIS spectrophotometer. The DPPH radical scavenging rate of samples was calculated using the following equation:
solution is obtained by mixing 10 mL stock solution with 45 mL methanol until an absorbance of 1.1 0.02 units at 515 nm is obtained using the spectrophotometer. CP flour extracts (0.150 mL) were allowed to react with 2.85 mL of the DPPH solution for 2 h in the dark.
Absorbance is measured at 515 nm using a UV-VIS spectrophotometer. The DPPH radical scavenging rate of samples was calculated using the following equation:
[0066] Inhibition % = [(A blank ¨ A sample) / A blank] x 100
[0067] A_blank is the absorbance of solvent, and A sample is the absorbance of the samples. The standard curve was linear between 25 and 800 1.1M of the synthetic antioxidant Trolox. Results are expressed in [tM Trolox equivalent (TE)/g dry mass as mean of three replicates.
[0068] Results shown in Table 3 demonstrate that CP flour samples have the ability to scavenge DPPH free radicals. Among the three treatments, freeze drying and microwave methodologies show similar antioxidant potential, whereas conventional oven drying showed the lowest antioxidant capacity. These results suggest that phenolic content may play an important role in determining antioxidant activity. Some polyphenols changes can occur during dehydration and could be related to the formation of new compounds or to the formation of polyphenols derivatives with higher antioxidant activity. CP flour displays dose-dependent antioxidant activity as per the DPPH assay (independently of method used to dry it) with a positive and significant correlation, freeze drying (r2=0.9786), conventional drying (r2=0.9561) and microwave drying (r2=
0.9633).
0.9633).
[0069] For the ABTS (2, 2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid)) assay, the procedure followed the method described by Martinez et al., 2012. The stock solutions included Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 7.4 mM ABTS+ solution and 2.6 mM potassium persulfate solution. The working solution was then prepared by mixing the two stock solutions in equal quantities and allowing them to react for 12-16 h at room temperature in the dark. The solution is then diluted by mixing 1 mL ABTS+
solution with 60 mL methanol to obtain an absorbance of 1.1 0.02 units at 734 nm. CP flour extracts (150 [IL) were allowed to react with 2850 pL of the ABTS+ solution for 2 h in a dark condition and then the absorbance was measured at 734 nm. The standard curve was linear between 25 and 800 uM of the synthetic antioxidant Trolox. Results are expressed in [tM Trolox equivalents (TE)/g dry mass.
solution with 60 mL methanol to obtain an absorbance of 1.1 0.02 units at 734 nm. CP flour extracts (150 [IL) were allowed to react with 2850 pL of the ABTS+ solution for 2 h in a dark condition and then the absorbance was measured at 734 nm. The standard curve was linear between 25 and 800 uM of the synthetic antioxidant Trolox. Results are expressed in [tM Trolox equivalents (TE)/g dry mass.
[0070]
The ABTS assay results are shown in Table 3. Drying methods generated a significantly increase (p<0.05) in antioxidant activity with freeze drying of the CP flours which yielding the highest values. The higher antioxidant activity may be related to a better extractability of antioxidant compounds from the pericarp matrix using this method.
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
The ABTS assay results are shown in Table 3. Drying methods generated a significantly increase (p<0.05) in antioxidant activity with freeze drying of the CP flours which yielding the highest values. The higher antioxidant activity may be related to a better extractability of antioxidant compounds from the pericarp matrix using this method.
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
[0071] Table 3. Antioxidant activity of fresh and dry CP flour measured by the DPPH and ABTS methods.
Sample ABTS (uM TE/g dm) DPPH (uM TE/g dm) Fresh 30.9 1.24 17 1.5 OHD 208 7.70* 47 2.3*
MWD 255 10.9* 48 1.3*
FD 317 24.5* 175 14*
Sample ABTS (uM TE/g dm) DPPH (uM TE/g dm) Fresh 30.9 1.24 17 1.5 OHD 208 7.70* 47 2.3*
MWD 255 10.9* 48 1.3*
FD 317 24.5* 175 14*
[0072] In Table 3, OHD-oven heating drying, MWD-microwave drying, and FD-freeze drying. The antioxidant activity was expressed as 1.1M Trolox equivalent (TE) of dry mass (dm).
* = (p<0.05) vs fresh.
* = (p<0.05) vs fresh.
[0073] Example 3: Clinical eight-week clinical regimen using human subjects.
[0074] A placebo controlled clinical trial using a baked cookie food product can be used to demonstrate the beneficial effects of the pericarp flour consumed by humans and animals.
Several clinical endpoints can be considered, including: body weight; body mass index (BMI);
abdominal circumference; body fat; muscle mass; blood triglycerides (TG);
blood glucose; blood cholesterol; blood LDL cholesterol; blood HDL cholesterol; TG/HDL ratio;
LDL/HDL ration; and left hand grip strength.
Several clinical endpoints can be considered, including: body weight; body mass index (BMI);
abdominal circumference; body fat; muscle mass; blood triglycerides (TG);
blood glucose; blood cholesterol; blood LDL cholesterol; blood HDL cholesterol; TG/HDL ratio;
LDL/HDL ration; and left hand grip strength.
[0075] Subject are recruited under the following criteria: Men or women from 20 to 60 years of age; BMI of >25 kg/m2 to < 29.9 kg/m2; and blood triglycerides 150 -350 mg/dL.
Subjects are excluded for any of the following: Type 2 diabetes mellitus;
dyslipidemia;
hypertension; cardiovascular diseases; subjects treated with hypolipidemic drugs, metformin or steroids; pregnancy or surgery in the last 6 months; lupus; arthritis;
hypothyroidism; HIV or Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 treatment with anti-retrovirals; alcohol or tobacco consumers; and a history of allergy to chocolate or components of cocoa.
Subjects are excluded for any of the following: Type 2 diabetes mellitus;
dyslipidemia;
hypertension; cardiovascular diseases; subjects treated with hypolipidemic drugs, metformin or steroids; pregnancy or surgery in the last 6 months; lupus; arthritis;
hypothyroidism; HIV or Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 treatment with anti-retrovirals; alcohol or tobacco consumers; and a history of allergy to chocolate or components of cocoa.
[0076] Two groups, placebo/control and experimental, are recruited. Both groups (placebo and experimental, n=20 subjects per group) received nutritional counseling advising them to reduce 250 kilocalories/day from their usual diet and to perform moderate exercise so as to burn another 250 kilocalories/day.
[0077] After randomization to either group, the placebo group received control cookies (-4 g and 14 Kcal) twice daily, one in the morning and one in the afternoon, before meals. Subjects in the experimental group received CP flour supplemented cookies (-4 g and 14 Kcal) containing 12.5 mg of total flavanols measured in equivalents of (-)-epicatechin, twice a day, one in the morning and one in the afternoon, before meals. Subjects, scientists and clinical laboratory technicians were blinded to treatment groups.
[0078] Baseline characteristics of recruited subjects are shown in Table 4. Both groups were equivalent at the beginning of 8-week trial.
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
[0079] Table 4. Baseline characteristics of placebo and experimental groups.
GROUP B
GROUP A
(PLACEBO) (CP PERICARP P
FLOUR) GROUP SIZE (N) (MALE=4, (MALE=3, FEIVIALE=16) FEIVIALE=17) AGE 40.6 +2.4 48.3 +1.9 0.006 BODY WEIGTH (KG) 69.7 + 2.2 66 + 1.2 0.7 BMI (KG/M2) 27.8 + 0.4 27.9 + 0.3 0.3 ABDOMINAL
91.5 + 1.3 87.9 + 1.3 0.5 CIRCUMFERENCE (CM) % BODY FAT 35 + 1.3 35.4 + 0.6 0.7 MUSCLE MASS (KG) 43.4 + 2.1 40.5 + 1.02 0.1 TRIGLYCERIDES (MG/DL) 207.8 + 15.8 189.8 +
17.6 0.5 GLUCOSE (MG/DL) 84 + 2.3 89.5 3.1 0.2 CHOLESTEROL (MG/DL) 178.5 + 7.9 204.8 +13.4 0.1 C-LDL (MG/DL) 98.8 + 7.5 124.8 +
11.1 0.07 C-HDL (MG/DL) 38.1 + 1.8 42 + 2.0 0.1 TGL/HDL INDEX 5.6 + 0.5 4.9+ 0.4 0.06 LDL/HDL INDEX 3.2 + 0.2 3.0 + 0.3 0.3
GROUP B
GROUP A
(PLACEBO) (CP PERICARP P
FLOUR) GROUP SIZE (N) (MALE=4, (MALE=3, FEIVIALE=16) FEIVIALE=17) AGE 40.6 +2.4 48.3 +1.9 0.006 BODY WEIGTH (KG) 69.7 + 2.2 66 + 1.2 0.7 BMI (KG/M2) 27.8 + 0.4 27.9 + 0.3 0.3 ABDOMINAL
91.5 + 1.3 87.9 + 1.3 0.5 CIRCUMFERENCE (CM) % BODY FAT 35 + 1.3 35.4 + 0.6 0.7 MUSCLE MASS (KG) 43.4 + 2.1 40.5 + 1.02 0.1 TRIGLYCERIDES (MG/DL) 207.8 + 15.8 189.8 +
17.6 0.5 GLUCOSE (MG/DL) 84 + 2.3 89.5 3.1 0.2 CHOLESTEROL (MG/DL) 178.5 + 7.9 204.8 +13.4 0.1 C-LDL (MG/DL) 98.8 + 7.5 124.8 +
11.1 0.07 C-HDL (MG/DL) 38.1 + 1.8 42 + 2.0 0.1 TGL/HDL INDEX 5.6 + 0.5 4.9+ 0.4 0.06 LDL/HDL INDEX 3.2 + 0.2 3.0 + 0.3 0.3
[0080] The results of placebo and pericarp flour treated subjects are shown in Tables 5 and 6.
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
[0081] Table 5. Anthropometric data after 8 weeks of cookie intake.
Group A Group B
placebo Cacao Pericarp Flour Basal Final p Basal Final Body weight (kg) 69.7 + 2.2 67.2 + 2.3 <0.001 66.0 + 1.2 62.8+ 1.1 <0.0001 Bmi (Kgirn2) 27.8 + 0.4 26.8 + 0.5 <0.001 27.9 + 0.3 26.6 + 0.3 <0.0001 Abdominal Circumference 91.5 + 1.4 87.7 + 1.7 <0.001 87.9 + 1.3 84.0 + 1.6 <0.0001 (cm) % Body fat 35 + 1.3 33.7 + 1.4 <0.01 35.4 + 0.6 35.0 0.8 0.2 Muscle mass (kg) 43.4 + 2.1 42.4 + 2 <0.05 40.5 + 1.0 38.6 + 0.8 <0.0001 Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
Group A Group B
placebo Cacao Pericarp Flour Basal Final p Basal Final Body weight (kg) 69.7 + 2.2 67.2 + 2.3 <0.001 66.0 + 1.2 62.8+ 1.1 <0.0001 Bmi (Kgirn2) 27.8 + 0.4 26.8 + 0.5 <0.001 27.9 + 0.3 26.6 + 0.3 <0.0001 Abdominal Circumference 91.5 + 1.4 87.7 + 1.7 <0.001 87.9 + 1.3 84.0 + 1.6 <0.0001 (cm) % Body fat 35 + 1.3 33.7 + 1.4 <0.01 35.4 + 0.6 35.0 0.8 0.2 Muscle mass (kg) 43.4 + 2.1 42.4 + 2 <0.05 40.5 + 1.0 38.6 + 0.8 <0.0001 Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
[0082] Table 6. Blood cardiometabolic endpoint values after 8 weeks of cookie intake.
Group A Group B
Placebo Cacao Pericarp Flour BASAL FINAL P BASAL FINAL P
Triglycerides 207.8 + 15.8 185.9 + 22.4 0.20 204.2 17.4 149.3 + 12.1 0.003 (mg/dL) Glucose 5. 91 + 3 84 + 2.3 80.7 + 2.1 0.06 81.09 + 2.9 0.01 (mg/dL) Cholesterol 178.5 + 7.9 171.8 + 10.9 0.18 217.8 11.7 205.7 + 14.7 0.18 (mg/c11.) LDL (mg/dL) 98.80 + 7.5 97.70 + 10.9 0.44 134.1 9.7 130.2 + 11.4 0.37 HDL (mg/dL) 38.1 + 1.8 37 + 2.2 0.26 42.6 + 2.02 45.6 + 3.6 0.17 TG/HDL 5.6 + 0.5 5.4 + 0.8 0.38 4.9 + 0.4 3.4 + 0.3 0.008 LDL/HDL 3.2 + 0.2 3.3 + 0.2 0.30 3.2 + 0.3 2.9 + 0.19 0.19
Group A Group B
Placebo Cacao Pericarp Flour BASAL FINAL P BASAL FINAL P
Triglycerides 207.8 + 15.8 185.9 + 22.4 0.20 204.2 17.4 149.3 + 12.1 0.003 (mg/dL) Glucose 5. 91 + 3 84 + 2.3 80.7 + 2.1 0.06 81.09 + 2.9 0.01 (mg/dL) Cholesterol 178.5 + 7.9 171.8 + 10.9 0.18 217.8 11.7 205.7 + 14.7 0.18 (mg/c11.) LDL (mg/dL) 98.80 + 7.5 97.70 + 10.9 0.44 134.1 9.7 130.2 + 11.4 0.37 HDL (mg/dL) 38.1 + 1.8 37 + 2.2 0.26 42.6 + 2.02 45.6 + 3.6 0.17 TG/HDL 5.6 + 0.5 5.4 + 0.8 0.38 4.9 + 0.4 3.4 + 0.3 0.008 LDL/HDL 3.2 + 0.2 3.3 + 0.2 0.30 3.2 + 0.3 2.9 + 0.19 0.19
[0083] Physical results after 8 weeks of cookie supplementation are summarized in Table 5. Diet and exercise counseling induced favorable changes in both groups, but there are no differences between groups. Changes in cardiometabolic blood markers are summarized in Table 6. The consumption of placebo cookies induced no significant changes in any of markers evaluated. In contrast, consumption of the experimental (containing cacao pericarp flour) cookies induced positive and significant changes in triglycerides, glucose and TG/HDL
ratio. HDL
decreased slightly in placebo group and shows a non-significant increase in experimental group.
These results indicate a decrease in cardiometabolic risk in subjects who consumed CP flour Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 supplemented cookies. The experimental (cacao pericarp flour) group evidences a surprisingly significant decrease in blood triglycerides levels.
ratio. HDL
decreased slightly in placebo group and shows a non-significant increase in experimental group.
These results indicate a decrease in cardiometabolic risk in subjects who consumed CP flour Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 supplemented cookies. The experimental (cacao pericarp flour) group evidences a surprisingly significant decrease in blood triglycerides levels.
[0084] Left hand grip strength (non-dominant hand) can be evaluated before and after treatment with placebo or CP flour containing cookies with a dynamometer (Camry Grip Strength Dynamometer, City of Industry, CA). Subjects are instructed to apply as much force as they can.
Test was repeated 3 times (30 seconds between tests), the highest result was recorded. Differences at the beginning of study and at the end (8 weeks) were compared in both groups.
Test was repeated 3 times (30 seconds between tests), the highest result was recorded. Differences at the beginning of study and at the end (8 weeks) were compared in both groups.
[0085] Subjects in the placebo group show no change in hand grip strength. However, the ingestion of CP flour cookies does induce a significant increase in hand grip strength (Figure 4).
[0086] Example 4:
[0087] The following pertains to the manufacturing and use of a topical cream using the cacao pericarp (CP) flour and proof of its beneficial effects on human skin.
For this study, a control cream (control cream) was manufactured and compared with the same cream in which CP flour was added (CP cream). The basic cream ingredients are noted in the table below:
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
For this study, a control cream (control cream) was manufactured and compared with the same cream in which CP flour was added (CP cream). The basic cream ingredients are noted in the table below:
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
[0088] Table 7. Components of Exemplary Topical Cream (CP Cream).
COMPONENT QUANTITY (GRAMS UNLESS NOTED
OTHERWISE) DISTILLED WATER 675 (ML) CP FLOUR (PRESENT ONLY IN CP CREAM) 0.1%
COMPONENT QUANTITY (GRAMS UNLESS NOTED
OTHERWISE) DISTILLED WATER 675 (ML) CP FLOUR (PRESENT ONLY IN CP CREAM) 0.1%
[0089] Experimental set up.
[0090] Analysis of cream effects on hand wrinkles and skin color.
Subjects (n=22, 45-65 years old) of both genders were randomly assigned to either, a) control cream (n= 10) or b) CP
cream (n= 12). Subjects were instructed to apply approximately 200 microliters of cream every morning on the back of the right hand and to extend it uniformly over the hand every day for a period of 4 weeks.
Subjects (n=22, 45-65 years old) of both genders were randomly assigned to either, a) control cream (n= 10) or b) CP
cream (n= 12). Subjects were instructed to apply approximately 200 microliters of cream every morning on the back of the right hand and to extend it uniformly over the hand every day for a period of 4 weeks.
[0091] For hand wrinkle analysis, images were taken on the back of the hand using a cast to place the arm in the same uniform position while holding a 3 cm cylinder.
Images were recorded using a Multifunction UV Skin Analysis System (Skin Scope Analyzer EH-2100) at approximately Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 the same spot (middle part of the hand). The analysis of the images acquired was performed using image J computer software and the following wrinkle endpoints were generated:
1) total height of the wrinkle profile (Rt), 2) highest peak (Rp) and, 3) lowest valley (Rv).
Changes in hand wrinkles were analyzed comparing Rt, Rp and Rv before and after 4 weeks of treatment using a paired t-test (statistically different if p<0.05). No statistical differences were detected in Rt, Rp and Rv with the control cream. As illustrated in Figure 5 and summarized in Figure 6 with the CP cream, significant decreases were detected in the lowest valley (Rv) and consequently, in the total height profile (Rt) of the wrinkles (i.e., a flatter skin profile develops).
Images were recorded using a Multifunction UV Skin Analysis System (Skin Scope Analyzer EH-2100) at approximately Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 the same spot (middle part of the hand). The analysis of the images acquired was performed using image J computer software and the following wrinkle endpoints were generated:
1) total height of the wrinkle profile (Rt), 2) highest peak (Rp) and, 3) lowest valley (Rv).
Changes in hand wrinkles were analyzed comparing Rt, Rp and Rv before and after 4 weeks of treatment using a paired t-test (statistically different if p<0.05). No statistical differences were detected in Rt, Rp and Rv with the control cream. As illustrated in Figure 5 and summarized in Figure 6 with the CP cream, significant decreases were detected in the lowest valley (Rv) and consequently, in the total height profile (Rt) of the wrinkles (i.e., a flatter skin profile develops).
[0092] From the same images acquired, color changes were analyzed using a different image J software option (color inspector 3D plugin). As summarized in Figure 7, the CP cream managed to reduce skin pigmentation to a lighter overall intensity.
[0093] The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of any method or approach.
As used herein, the singular forms "a," "an," and "the" are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms "comprises" and/or "comprising," when used in this specification, specify the presence of stated features, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and/or groups thereof.
As used herein, the singular forms "a," "an," and "the" are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms "comprises" and/or "comprising," when used in this specification, specify the presence of stated features, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and/or groups thereof.
[0094] The invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the claims of the application rather than by the foregoing description, and all changes which come Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Date Recue/Date Received 2020-08-12
Date Recue/Date Received 2020-08-12
Claims (36)
1. A method for the preparation of flour from cacao fruit comprising isolating pericarp material from cacao pods, wherein the pericarp material is free of cacao seeds and pulp, grinding the pericarp material to a paste, freeze drying the paste under vacuum pressure to a moisture level of less than 10%, and further grinding the dried paste to form a flour composition.
2. The method of claim 1, wherein the drying is maintained until the moisture level is 8% or less.
3. The method of claim 1, wherein the dried paste is ground until the average particle size is 0.500 mm or less.
4. The method of claim 2, wherein the dried paste is ground until the average particle size is 0.425 mm or less.
5. The method of claim 1, further comprising measuring the total polyphenol content of the pericarp material or the flour composition.
6. The method of claim 1, further comprising measuring the total flavonoid content of the pericarp material or the flour composition.
7. The method of claim 1, further comprising measuring the total antioxidant content of the pericarp material or the flour composition.
8. The method of claim 1, further comprising using the flour composition to prepare a food product.
9. A method for the preparation of flour from cacao pod husk comprising isolating pericarp material from cacao pods, wherein the pericarp material is free of cacao seeds and pulp, grinding the pericarp material to a paste, microwave drying the paste to a moisture level of less than 10%, and then grinding the dried pericarp material to fonn a flour composition.
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
10. The method of claim 9, wherein the drying is maintained until the moisture level is 8% or less.
11. The method of claim 9, wherein the dried paste is ground until the average particle size is 0.500 mm or less.
12. The method of claim 9, wherein the dried paste is ground until the average particle size is 0.425 mm or less.
13. The method of claim 9, further comprising measuring the total polyphenol content of the pericarp material or the flour composition.
14. The method of claim 9, further comprising measuring the total flavonoid content of the pericarp material or the flour composition.
15. The method of claim 9, further comprising measuring the total antioxidant content of the pericarp material or the flour composition.
16. The method of claim 9, further comprising using the flour composition to prepare a food product.
17. A prophylactic method of treating a human subject comprising providing a cacao pod husk ingredient derived only from the pericarp of the pod, and administering the ingredient daily at an amount that delivers the total polyphenol content equivalent to about 12 mg of (-)-epicatechin per dose twice per day.
18. The method of claim 17, further comprising monitoring one of more of the following cardiometabolic markers in the blood of the subject: triglyceride levels; LDL
levels; glucose levels;
LDL/HDL ratio, Body Mass Index, muscle mass, or triglyceride/HDL ratio.
levels; glucose levels;
LDL/HDL ratio, Body Mass Index, muscle mass, or triglyceride/HDL ratio.
19. A method of lowering blood triglyceride levels in a human subject with elevated levels of triglycerides comprising preparing a composition comprising an effective dose of a cacao pericarp Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003 flour or extract of cacao pericarp material, and orally administering the composition daily to the subject daily.
20. The method of claim 17, wherein the subject has triglycerides levels between 150 - 350 mg/dL prior to the treatment.
21. The method of claim 17, wherein the composition is administered prior to a meal.
22. The method of claim 17, wherein the composition is administered during a meal.
23. The method of claim 17, wherein the composition is administered between meals.
24. The method of claim 17, wherein the composition is administered daily prior to each meal.
25. The method of using of CP flour made from the method of claim 1, further comprising adding CP flour to food, beverage or supplements to lower triglycerides in humans.
26. The method of claim 25, further comprising adding CP flour to food, beverage or supplements to lower blood glucose in humans.
27. The method of claim 25, further comprising adding CP flour to food, beverage or supplements to decrease LDL/HDL ratios in humans.
28. The method of claim 25, further comprising adding CP flour to food, beverage or supplements to decrease Triglyceride/HDL ratios in humans.
29. The method of claim 25, further comprising adding CP flour to food, beverage or supplements to reduce waist circumference in humans.
30. The method of claim 25, further comprising adding CP flour to food, beverage or supplements to reduce Body Mass Index in humans.
31. The method of claim 25, further comprising adding CP flour to food, beverage or supplements to increase muscle mass in humans.
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
Date Recue/Date Received 2020-08-12 Attorney Docket No. 073616.0003
32. The method of claim 25, further comprising adding CP flour to food, beverage or supplements to increase muscle grip strength in humans.
33. A topical cosmetic composition comprising a CP flour composition and a cosmetically acceptable carrier.
34. The composition of claim 33, further comprising one or more of: (a) a source of bio-retinol (b) a source of retinol-like activity; (c) a source of sodium hyaluronic acid or other cosmetically active acid; (d) a source of moisturizing saccharide complex; (e) an ascorbic acid source; and (f) a source of anti-oxidant components.
35. A method of treating skin by topical administration of a CP flour comprising providing a composition of claim 33 and applying it to the skin of a patient at least once per day.
36. The method of claim 35, wherein the CP flour is present in the composition at a range from 0.1% to 1% by weight.
Date Recue/Date Received 2020-08-12
Date Recue/Date Received 2020-08-12
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762458408P | 2017-02-13 | 2017-02-13 | |
US62/458,408 | 2017-02-13 | ||
PCT/MX2018/000012 WO2018147718A2 (en) | 2017-02-13 | 2018-02-13 | Cocoa pericarp compositions and method for producing same |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3091105A1 true CA3091105A1 (en) | 2018-08-16 |
Family
ID=63107692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3091105A Pending CA3091105A1 (en) | 2017-02-13 | 2018-02-13 | Compositions from cacao pericarp and methods of producing and using them |
Country Status (2)
Country | Link |
---|---|
CA (1) | CA3091105A1 (en) |
WO (1) | WO2018147718A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE1027210B1 (en) * | 2019-09-20 | 2020-11-17 | Cabosse Naturals Nv | COCOAOPEUL PEEL POWDER, METHOD FOR PREPARATION AND USE IN FOOD, PHARMACEUTICAL AND COSMETIC COMPOSITIONS |
BE1027209B1 (en) * | 2019-09-20 | 2020-11-17 | Cabosse Naturals Nv | PROCESS FOR EXTRACTING COMPONENTS OF CACAOPEUL SHELLS AND CACAOPLACENTA, AND USING CACA FRUIT-SOLUBLE EXTRACT OBTAINED FROM THESE AND ITS USES |
BE1027685B1 (en) * | 2020-04-17 | 2021-05-11 | Puratos | FOOD COMPOSITION CONTAINING THE COVERING OF COCOA BEANS |
US20220039446A1 (en) * | 2020-08-04 | 2022-02-10 | Intercontinental Great Brands Llc | Comestible Products |
BE1027918B1 (en) * | 2020-11-16 | 2021-07-16 | Puratos | NUTRITIONAL COMPOSITION CONTAINING COCOA BEANS SHELL |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101163407A (en) * | 2005-02-21 | 2008-04-16 | 西欧西营养股份公司 | Method of obtaining avocado powder |
-
2018
- 2018-02-13 WO PCT/MX2018/000012 patent/WO2018147718A2/en active Application Filing
- 2018-02-13 CA CA3091105A patent/CA3091105A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2018147718A3 (en) | 2019-03-14 |
WO2018147718A8 (en) | 2019-09-26 |
WO2018147718A2 (en) | 2018-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA3091105A1 (en) | Compositions from cacao pericarp and methods of producing and using them | |
JP4658348B2 (en) | Collagen production promoter, collagenase inhibitor, fibroblast proliferation agent, elastase inhibitor, estrogen-like agent, and skin cosmetics | |
CN101925359B (en) | Composition | |
CN102224131B (en) | Novel compound ramalin, and use thereof | |
JP2009263275A (en) | Antioxidant and cosmetic product, food and drink composition and pharmaceutical composition containing the same | |
KR100855199B1 (en) | Functional foods containing sphingoglycolipids and a process for its production | |
JP5013673B2 (en) | Orally administrable composition for improving hair and coat quality | |
JP4658290B2 (en) | Fibroblast proliferating agent, cosmetic food and drink, and skin cosmetics | |
JP2009057481A (en) | Antioxidant composition | |
JP2002293736A (en) | Maillard reaction inhibitor and composition containing the same | |
Tufail et al. | Functional and nutraceutical scenario of flaxseed and sesame | |
JP2010265251A (en) | Bloodstream-promoting/improving agent | |
WO2008029877A1 (en) | Anti-aging agent, skin-whitening agent, anti-oxidative agent, and anti-inflammatory agent | |
JP5597828B2 (en) | Hair restorer | |
JP5405067B2 (en) | Antioxidant composition containing bee pup | |
US20190357560A1 (en) | Compositions from cacao pericarp and methods of producing and using them | |
JP2011055837A (en) | Food and drink for beautification | |
JP6844857B2 (en) | A skin moisturizing composition containing acacia bark-derived products | |
CN101815523B (en) | Cocoa extract for use in providing skin benefits | |
JP2003137801A (en) | Collagen production promoter, collagenase inhibitor, fibroblast cell-propagating agent, skin cosmetic material and food or beverage for cosmetic use | |
CN101528245A (en) | Composition for amelioration of skin condition | |
JP2007269659A (en) | Antioxidant composition | |
JP5341422B2 (en) | Antioxidant composition containing bee candy and royal jelly | |
JP7296611B2 (en) | Nitric oxide production accelerator | |
JP6326611B2 (en) | CMA production inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20230209 |
|
EEER | Examination request |
Effective date: 20230209 |
|
EEER | Examination request |
Effective date: 20230209 |